Looking forward to Wednesday. Thanks to all that are discussing the ongoing ramifications relative to Leronlimab. I have to admit it is a bit hard getting back to earth after the events today and over the weekend relative to IMMU but I think CYDY may be the next big winner both for us stockowners but more importantly for patients all over the world with difficult to cure diseases that can be helped with our favorite MAB.